Selected research
Industry Growth & Trends
Global Women’s Health Diagnostics Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Women’s Health Diagnostics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Women’s Health Diagnostics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Women’s Health Diagnostics is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Women’s Health Diagnostics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Women’s Health Diagnostics market include Siemens, Roche, Philips, Quest Diagnostics Inc., Perkinelmer Inc., Hologic, Inc., GE Healthcare, Biomerieux SA and Becton, Dickinson and Company, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Women’s Health Diagnostics market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Women’s Health Diagnostics market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Women’s Health Diagnostics market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Women’s Health Diagnostics.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Women’s Health Diagnostics market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Women’s Health Diagnostics Market by Company
Siemens
Roche
Philips
Quest Diagnostics Inc.
Perkinelmer Inc.
Hologic, Inc.
GE Healthcare
Biomerieux SA
Becton, Dickinson and Company
Alere Inc.
Abbott Laboratories
Women’s Health Diagnostics Segment by Type
Diagnostic Devices
Diagnostic Tests
Women’s Health Diagnostics Segment by Application
Infectious Disease Testing
Osteoporosis Testing
Pregnancy and Fertility Testing
Breast Cancer
Sexually Transmitted Disease Testing
Others
Women’s Health Diagnostics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Women’s Health Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Women’s Health Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Women’s Health Diagnostics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Women’s Health Diagnostics companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Diagnostic Devices
- Diagnostic Tests
Applications
- Infectious Disease Testing
- Osteoporosis Testing
- Pregnancy and Fertility Testing
- Breast Cancer
- Sexually Transmitted Disease Testing
- Others
Companies covered
- Siemens
- Roche
- Philips
- Quest Diagnostics Inc.
- Perkinelmer Inc.
- Hologic, Inc.
- GE Healthcare
- Biomerieux SA
- Becton, Dickinson and Company
- Alere Inc.
- Abbott Laboratories
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Women’s Health Diagnostics Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Women’s Health Diagnostics Market Size by Region (2021-2032)
- 1.4.1 Global Women’s Health Diagnostics Market Size by Region (2021-2026)
- 1.4.2 Global Women’s Health Diagnostics Market Size by Region (2027-2032)
- 1.5 Key Regions Women’s Health Diagnostics Market Size (2021-2032)
- 1.5.1 North America Women’s Health Diagnostics Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Women’s Health Diagnostics Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Women’s Health Diagnostics Market Size Growth Rate (2021-2032)
- 1.5.4 South America Women’s Health Diagnostics Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Women’s Health Diagnostics Market Size Growth Rate (2021-2032)
2 Women’s Health Diagnostics Market by Type
- 2.1 Type Introduction
- 2.1.1 Diagnostic Devices
- 2.1.2 Diagnostic Tests
- 2.2 Global Women’s Health Diagnostics Market Size by Type
- 2.2.1 Global Women’s Health Diagnostics Market Size Overview by Type (2021-2032)
- 2.2.2 Global Women’s Health Diagnostics Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Women’s Health Diagnostics Market Size Forecasted by Type (2027-2032)
- 2.3 Global Women’s Health Diagnostics Market Size by Regions
- 2.3.1 North America Women’s Health Diagnostics Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Women’s Health Diagnostics Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Women’s Health Diagnostics Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Women’s Health Diagnostics Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Women’s Health Diagnostics Market Size Breakdown by Type (2021-2026)
3 Women’s Health Diagnostics Market by Application
- 3.1 Type Introduction
- 3.1.1 Infectious Disease Testing
- 3.1.2 Osteoporosis Testing
- 3.1.3 Pregnancy and Fertility Testing
- 3.1.4 Breast Cancer
- 3.1.5 Sexually Transmitted Disease Testing
- 3.1.6 Others
- 3.2 Global Women’s Health Diagnostics Market Size by Application
- 3.2.1 Global Women’s Health Diagnostics Market Size Overview by Application (2021-2032)
- 3.2.2 Global Women’s Health Diagnostics Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Women’s Health Diagnostics Market Size Forecasted by Application (2027-2032)
- 3.3 Global Women’s Health Diagnostics Market Size by Regions
- 3.3.1 North America Women’s Health Diagnostics Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Women’s Health Diagnostics Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Women’s Health Diagnostics Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Women’s Health Diagnostics Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Women’s Health Diagnostics Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Women’s Health Diagnostics Industry Trends
- 4.2 Women’s Health Diagnostics Industry Drivers
- 4.3 Women’s Health Diagnostics Industry Opportunities and Challenges
- 4.4 Women’s Health Diagnostics Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Women’s Health Diagnostics Revenue (2021-2026)
- 5.2 Global Women’s Health Diagnostics Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Women’s Health Diagnostics Key Company Headquarters & Area Served
- 5.4 Global Women’s Health Diagnostics Company, Product Type & Application
- 5.5 Global Women’s Health Diagnostics Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Women’s Health Diagnostics Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Women’s Health Diagnostics Players Market Share by Revenue in 2025
- 5.6.3 2025 Women’s Health Diagnostics Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Siemens
- 6.1.1 Siemens Company Information
- 6.1.2 Siemens Business Overview
- 6.1.3 Siemens Women’s Health Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Siemens Women’s Health Diagnostics Product Portfolio
- 6.1.5 Siemens Recent Developments
- 6.2 Roche
- 6.2.1 Roche Company Information
- 6.2.2 Roche Business Overview
- 6.2.3 Roche Women’s Health Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Roche Women’s Health Diagnostics Product Portfolio
- 6.2.5 Roche Recent Developments
- 6.3 Philips
- 6.3.1 Philips Company Information
- 6.3.2 Philips Business Overview
- 6.3.3 Philips Women’s Health Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Philips Women’s Health Diagnostics Product Portfolio
- 6.3.5 Philips Recent Developments
- 6.4 Quest Diagnostics Inc.
- 6.4.1 Quest Diagnostics Inc. Company Information
- 6.4.2 Quest Diagnostics Inc. Business Overview
- 6.4.3 Quest Diagnostics Inc. Women’s Health Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Quest Diagnostics Inc. Women’s Health Diagnostics Product Portfolio
- 6.4.5 Quest Diagnostics Inc. Recent Developments
- 6.5 Perkinelmer Inc.
- 6.5.1 Perkinelmer Inc. Company Information
- 6.5.2 Perkinelmer Inc. Business Overview
- 6.5.3 Perkinelmer Inc. Women’s Health Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Perkinelmer Inc. Women’s Health Diagnostics Product Portfolio
- 6.5.5 Perkinelmer Inc. Recent Developments
- 6.6 Hologic, Inc.
- 6.6.1 Hologic, Inc. Company Information
- 6.6.2 Hologic, Inc. Business Overview
- 6.6.3 Hologic, Inc. Women’s Health Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Hologic, Inc. Women’s Health Diagnostics Product Portfolio
- 6.6.5 Hologic, Inc. Recent Developments
- 6.7 GE Healthcare
- 6.7.1 GE Healthcare Company Information
- 6.7.2 GE Healthcare Business Overview
- 6.7.3 GE Healthcare Women’s Health Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 GE Healthcare Women’s Health Diagnostics Product Portfolio
- 6.7.5 GE Healthcare Recent Developments
- 6.8 Biomerieux SA
- 6.8.1 Biomerieux SA Company Information
- 6.8.2 Biomerieux SA Business Overview
- 6.8.3 Biomerieux SA Women’s Health Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Biomerieux SA Women’s Health Diagnostics Product Portfolio
- 6.8.5 Biomerieux SA Recent Developments
- 6.9 Becton, Dickinson and Company
- 6.9.1 Becton, Dickinson and Company Company Information
- 6.9.2 Becton, Dickinson and Company Business Overview
- 6.9.3 Becton, Dickinson and Company Women’s Health Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Becton, Dickinson and Company Women’s Health Diagnostics Product Portfolio
- 6.9.5 Becton, Dickinson and Company Recent Developments
- 6.10 Alere Inc.
- 6.10.1 Alere Inc. Company Information
- 6.10.2 Alere Inc. Business Overview
- 6.10.3 Alere Inc. Women’s Health Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Alere Inc. Women’s Health Diagnostics Product Portfolio
- 6.10.5 Alere Inc. Recent Developments
- 6.11 Abbott Laboratories
- 6.11.1 Abbott Laboratories Company Information
- 6.11.2 Abbott Laboratories Business Overview
- 6.11.3 Abbott Laboratories Women’s Health Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Abbott Laboratories Women’s Health Diagnostics Product Portfolio
- 6.11.5 Abbott Laboratories Recent Developments
7 North America
- 7.1 North America Women’s Health Diagnostics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Women’s Health Diagnostics Market Size by Country (2021-2026)
- 7.3 North America Women’s Health Diagnostics Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Women’s Health Diagnostics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Women’s Health Diagnostics Market Size by Country (2021-2026)
- 8.3 Europe Women’s Health Diagnostics Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Women’s Health Diagnostics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Women’s Health Diagnostics Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Women’s Health Diagnostics Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Women’s Health Diagnostics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Women’s Health Diagnostics Market Size by Country (2021-2026)
- 10.3 South America Women’s Health Diagnostics Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Women’s Health Diagnostics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Women’s Health Diagnostics Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Women’s Health Diagnostics Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst